Cardioprotection - Wikipedia
Cardioprotection includes all mechanisms and means that contribute to the preservation of the heart by reducing or even preventing myocardial damage. [1] . Cardioprotection encompasses several regimens that have shown to preserve function and viability of cardiac muscle cell tissue subjected to ischemic insult or reoxygenation.
Cardioprotective Interventions: Where Are We? - American …
2016年7月21日 · Cardioprotective strategies include primary prevention and secondary prevention in those high-risk patients with subclinical cardiotoxicity. This review focuses on cardioprotective agents used in conjunction with cancer therapy. Radiation-induced heart disease and the treatment of cardiotoxicity are beyond the scope of this review.
The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors:
In this review, the authors first examine the established cardioprotective effects of SGLT2 inhibitors in heart failure and subsequently explore the existing body of evidence, including both preclinical and clinical studies, that supports the use of …
What is Cardioprotection? - News-Medical.net
2022年12月30日 · Cardioprotection refers to any intervention which seeks to decrease the risk of developing any adverse cardiovascular event; namely preserving the function of the heart by...
Cardioprotective drugs | The ESC Textbook of Preventive …
2015年6月1日 · Cardioprotective drugs are important in the treatment of patients at risk for or with documented cardiovascular disease. Beta-blockers are indicated after acute coronary syndromes, stable coronary artery disease, heart failure, and arrhythmias.
Recent Advances in Pharmacological and Non-Pharmacological …
Several intracellular signaling pathways mediated by chemical messengers (enzymes, protein kinases, transcription factors and others) and cytoplasmic organelles (mitochondria, sarcoplasmic reticulum, nucleus and sarcolemma) are involved in cardioprotective responses.
Cardioprotection: definition, classification, and fundamental ...
Cardioprotection: definition, classification, and fundamental principles. These references are in PubMed. This may not be the complete list of references from this article. Bristow M. R. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol. 1993 Oct;22 (4 Suppl A):61A–71A. doi: 10.1016/0735-1097 (93)90465-d.
Cardioprotection: The Role of β‐Blocker Therapy - PMC
Beta blockers are especially effective in preventing sudden death. In various trials and meta‐analyses, the cardioprotective benefits of β blockers extend to diabetic, elderly, and African‐American patients.
Scopoletin as a Cardioprotective Agent Against Cisplatin-Induced ...
5 天之前 · These findings highlight the potential of scopoletin as a cardioprotective agent in cancer chemotherapy regimens involving cisplatin, warranting further investigation into its clinical applications to improve patient outcomes without compromising the anti-cancer efficacy of cisplatin. The results of this study advocate for scopoletin's ...
Cardio protective drugs: Beta-blockers
2017年6月30日 · Cardiovascular effects: beta-blockers reduce heart rate, cardiac contractility, and systolic blood pressure. They also have anti-arrhythmic effects since they decrease spontaneous firing of ectopic pacemakers, slow conduction, and increase the refractory period of the atrioventricular (AV) node [1].